INTRODUCTION 1
Coxiella burnetii, the etiologic agent of acute and chronic Q fever, is an obligate 2 intracellular bacterium of worldwide distribution with a diverse host range. Livestock 3 serve as the organism's primary reservoir and may be asymptomatic carriers or exhibit 4 reproductive disorders. Ticks are important in the maintenance of the disease in nature 5
and have been shown to transmit the infection transovarially (37). Humans are most often 6 infected through inhalation of the bacterium in fine-particle aerosols, though transmission 7 may also occur through ingestion of the organism from contaminated, unpasteurized, 8 dairy products (22, 27) . Although a high percentage of infections may result in 9 subclinical or asymptomatic infection, humans can become ill from exposure to as few as 10 10 organisms (6) 1 organisms of the acute-disease-associated group I isolate Nine Mile RSA493 1 (NM) caused fever, but 10 6 chronic-disease-associated group IV isolate MSU Goat Q177 2 (Priscilla) organisms were required to induce fever (36) . 3
In opposition to the theory of genotype/pathotype correlation, Stein and Raoult 4 evaluated 28 human isolates and found that isolates bearing the QpH1 plasmid were 5 present in both acute and chronic Q fever patients in France, and isolates without the 6 QpH1 plasmid were able to cause acute disease (46). QpH1 plasmid-containing isolates 7 have also been isolated from chronic endocarditis patients (50). Several groups have 8 speculated that host factors are primarily responsible for the outcome of infection with C. 9
burnetii. Individual differences in immune function lead to varying sensitivity to 10 infection and disease development. In this model, acute and chronic disease could be 11 caused by organisms from the same isolate group, and chronic disease could develop 12 because of compromised resistance of the host rather than as a consequence of a specific 13 property of the pathogen. For example, HIV infection is a risk factor for the development 14 of chronic Q fever endocarditis (9, 29) . Deficiencies in the host specific cell-mediated 15 immune response in Q fever patients have been associated with the suppression of 16 monocyte and macrophage activity (25), and monocytes from chronic Q fever patients 17 have been shown to be defective in phagosome maturation and have impaired C. burnetii 18 killing potential, regulated in part by elevated interleukin-10 expression (14). There is 19 strong clinical evidence to support the role of increased host production of IL-10 in the 20 development of both Q fever endocarditis and chronic fatigue syndrome (11, 12, 21, 39) . 21
A recent study suggests that chronic Q fever endocarditis may be associated with an 22 on October 24, 2017 by guest http://iai.asm.org/ Downloaded from atypical M2 polarization and stimulation of bacterial replication (7) , but the pathogenic 1 process that mediates this polarization was undefined. 2
Route of infection may also be an important determining factor in the 3 manifestations of acute and chronic Q fever. LaScola and Marrie demonstrated that the 4 route of infection and size of inoculum affect clinical illness and pathology associated 5 with infection in mouse and guinea pig models (26, 33) . Differences in the geographic 6 distribution of disease have also been noted (32); in Nova Scotia, for example, the 7 primary manifestation of acute Q fever is pneumonia (34), but in France it is hepatitis, 8 possibly due to ingestion of raw milk and unpasteurized cheeses (51). 9
The pathogenicity of C. burnetii has been evaluated using guinea pigs, mice and 10 chicken embryos. Febrile response, splenomegaly and mortality in guinea pigs, 11 splenomegaly and mortality in mice, and mortality in chicken embryos are indicators of 12 virulence of C. burnetii. The establishment of an aerosol model of C. burnetii infection in 13 guinea pigs (43) provides a relevant model in which to test isolate virulence. 14 Additionally, severe combined immunodeficient (SCID) mice are highly sensitive to the 15 C. burnetii prototype (NM isolate) (1) , and the LD 50 of NM in SCID mice was at least 16 10 8 times less than in wild type mice. We speculated that with these highly sensitive 17 rodent models it may be possible to observe intra-and inter-group pathogenicity 18 differences of C. burnetii isolates. To confirm whether SCID mice could be used to 19 model isolate-specific virulence, we gave multiple infectious doses of a group IV Q fever 20 isolate to immune competent CB-17 and SCID mice (on the same background) to 21 compare with previously reported group I isolate (NM) infections (1) . Eight isolates from 22 four genomic groups (Table 1) were then evaluated for their ability to cause acute disease 23 on October 24, 2017 by guest http://iai.asm.org/ Downloaded from in SCID mouse intraperitoneal (IP)-challenge and guinea pig aerosol-challenge models. 1
We hypothesized that isolates within the same genotypic group would cause similar 2 disease and that there would be a distinct difference in disease manifestation between 3 isolate groups. Finally, we evaluated the potential protection of a vaccine composed of 4 one C. burnetii isolate in protecting guinea pigs against infection with an isolate from 5 another group since cross-protection between disparate isolate groups is a further 6 indication of antigenic relatedness. 7
MATERIALS AND METHODS 8
Animals. Female, six to seven week old CB-17/Icr-scid/scid (SCID) and wild 9 type CB-17/Icr-+/+ (CB-17) mice used in Japan were purchased from Japan CLEA 10 (Tokyo, Japan); A/J mice were purchased from Japan SLC (Shizuoka, Japan). A/J mice 11 were used because they are considered more susceptible to C. burnetii than other inbred 12 mouse strains (45). Female six to eight week old SCID and wild type CB-17 mice used in 13 the US were purchased from Taconic (Hudson, NY Mycoplasma detection set (Takara; Shiga, Japan), and inoculation of the spleen 10 homogenate to cell culture and SCID mice (independent experimental-infection from the 11 study described in this paper). Bacterial dose was evaluated as 50% tissue culture 12 infectious dose (TCID 50 ) in BGM cells (buffalo green monkey fibroblast), 50% infectious 13 dose (ID 50 ) in CB-17 mice, and 50% lethal dose (LD 50 ) in SCID mice. TCID 50 was 14 determined by detecting the bacteria 6 days after infection using immunofluorescence 15 staining with anti-C. burnetii rabbit antiserum. ID 50 was determined by detecting 16 seroconversion (IgG, >1:16) using indirect microimmunofluorescence. LD 50 was 17 determined as reported previously (1) . 18
For all subsequent experiments, all of the C. burnetii isolates were maintained at 19
Texas A&M Health Science Center. C. burnetii isolates were cultivated in embryonated 20 chicken eggs, purified by gradient centrifugation as previously reported (19, 44) , and 21 stored at -80°C until use. Absence of contamination by other pathogens was confirmed as 22 described above. C. burnetii was quantified by optical density (OD) (38), direct viable 23 on October 24, 2017 by guest http://iai.asm.org/ Downloaded from particle count using the LIVE/DEAD® BacLight™ Bacterial Viability Kit (Molecular 1 Probes; Eugene, OR), and quantitative real-time PCR (qPCR) using primers amplifying 2 the com1 gene (8) ( Table S1 ). The bacterial dose used for mouse infections was 3 determined by qPCR; guinea pig doses were calculated using OD. comparison. Four mice per group were used. Each of eight C. burnetii isolates described 10 in Table 1 (10 5 genome copies/animal) or PBS were administered IP to SCID and C.B-17 11 mice. Two independent infections were performed; mice were observed for 28 days (for 12 all the C. burnetii isolates in SCID and C.B-17 mice) or until death (four representative 13 C. burnetii isolates in SCID mice). 14 Clinical signs were evaluated every 2 days by visual observation (ruffled fur, 15 hunched back appearance and lethargy) and body weight measurement. Body weight 16 changes were evaluated using a body weight index (BWI). BWI = relative body weight / 17 mean relative body weight of the control group; relative body weight = body weight of 18 day "x" of infection/ body weight of the day of infection. Cachexia was diagnosed when 19 a mouse was lethargic and had a BWI less than 0.85. At necropsy, spleen weight was 20 measured as an indicator of C. burnetii infection (54) and tissues were collected. To 21 quantify growth of C. burnetii, DNA was extracted from spleen tissue and C. burnetii 22 com1 gene copies were detected by qPCR as previously described (8). Heart, lung, liver, 23
on October 24, 2017 by guest http://iai.asm.org/ Downloaded from spleen, kidney and femur were formalin-fixed, paraffin-embedded and sliced, then 1 prepared by hematoxylin-eosin staining and immunocytochemistry, as described 2 previously (1, 8) to evaluate histopathologic changes and bacterial distribution in tissues. 3
The degree of inflammation present in each tissue sample was scored numerically by the 4 following system: 0, none; 1, mild; 2, moderate; 3, marked; 4, severe. IgG titers for 5 phase I and II C. burnetii in the serum of C.B-17 mice were measured by micro-6 immunofluorescence as described elsewhere (1 was used for all guinea pig infection studies. 1) Three guinea pigs per group were 20 infected with low (10 2 ), mid (10 4 ), or high (10 6 ) doses of one of the phase I C. burnetii 21 isolates described in Table 1 . Four negative control animals were sham-infected with 22 sterile PBS. Body weight, rectal temperature, and behavioral attitude were recorded along 23 with any abnormalities noted on thoracic auscultation and abdominal palpation. A rectal 1 temperature ≥39.5°C was defined as fever. Guinea pigs were observed for 28 days post 2 infection (p.i.). Spleen and liver were weighed at necropsy. Tissues were collected and 3 formalin fixed for histopathologic evaluation. Serum was obtained from each animal for 4 serologic testing. 2) In a separate experiment, three guinea pigs per group were exposed 5 to PBS or 2x10 6 NM, P, G, or Dugway. Daily assessment of these animals was performed 6 as described above, and organs were weighed at necropsy 14 days p.i. to detect 7 splenomegaly and/or hepatomegaly. 3) In the heterologous protection study, guinea pigs 8
were vaccinated with 40µg of formalin-inactivated group I C. burnetii (NM) or group V 9 (S) in Freund's incomplete adjuvant or adjuvant alone twice, with two week intervals 10 between vaccinations and infection. Animals were then infected with high doses of either 11 NM or S. Three animals per group were separated into the following six groups: i) non-12 vaccinated, NM infected; ii) non-vaccinated, S infected; iii) NM vaccinated, NM 13 infected; iv) S vaccinated, S infected; v) NM vaccinated, S infected; and vi) S vaccinated, 14 NM infected. Guinea pigs were monitored for 14 days p.i. for development of fever and 15 other clinical signs of illness. 16 Histopathologic samples were prepared by hematoxylin and eosin staining or by 17 immunohistochemistry using Vectastain ABC kit and Vector NovaRED substrate kit 18 (Vector Laboratories; Burlingame, CA) and in-house generated rabbit anti-Nine Mile C. 19 burnetii (3) and counterstaining with hematoxylin. All slides were evaluated in a blinded 20 fashion. Serum samples collected at necropsy were tested by ELISA for IgG titers against 21 phase I NM C. burnetii antigen as previously described (43 LD 50 in C.B-17 mice could not be determined because no C.B-17 mice died with any 13 infectious dose used in this study, and the ID 50 in SCID mice could not be determined 14 due to lack of antibody production. The ID 50 in C.B-17 mice and the LD 50 in SCID mice 15 were similar, suggesting that SCID mice could be lethally infected with very few viable 16
organisms. 17
Multiple dose infection of SCID mice with Priscilla isolate resulted in slow, 18 progressive and long-term persistent disease. Clinical signs included ruffled fur, 19 extremely distended abdomens, and death. Body weight loss, inactivity, and cachexia 20
were not observed until a few days prior to death. Survival time ranged from 55 to 109 21 days p.i. Progression of clinical signs and survival time were dose dependent, with 22 shorter times corresponding to higher infectious doses (Table S2) Genomic group-specific virulence in mice. It is important to establish whether 11 the results of infection seen with the Priscilla isolate and those previously noted with the 12 NM isolate are genomic group-specific (24). To determine this, the pathogenicities of 13 multiple isolates were compared by delivering a single dose of eight C. burnetii isolates 14 from four genomic groups (Table 1) There was no mortality during the 28 day infection period. Clinical signs including 18 significant body weight loss (p<0.05) and cachexia, summarized in Figures 1A and S1A,  19 were most apparent in mice infected with group I isolates, followed by those given group 20 V, IV, then VI isolates, respectively. In C.B-17 mice, only mild transient disease was 21 noted with minimal loss of body weight in response to all isolates and noticeably ruffled 22 fur with group I isolate infection (FIG. 1B) . 23
Splenomegaly in response to infection was more severe in SCID than in C.B-17 1 mice (FIG. 2A) . The number of bacteria in the spleens was determined by qPCR (FIG.  2   2B ), and consistently higher numbers of com1 genes were detected in SCID compared to 3 C.B-17 mice. SCID mice showed phylogenetic group-characteristic spleen size and 4 growth of bacteria. Splenomegaly was greatest in SCID mice with mild clinical disease 5 infected with bacteria from groups IV and VI. However, the number of organisms in the 6 spleen was greater in mice with severe clinical disease following infection with 7 phylogenetic groups I and V. In C.B-17 mice, splenic enlargement and number of 8 bacteria increased with the severity of clinical disease. C.B-17 mice displayed differences 9 between infection with the acute C. burnetii isolates (phylogenetic group I) and chronic 10 C. burnetii isolates (phylogenetic groups IV and V), but there was no difference between 11 groups infected with chronic isolates. All infected mice except those infected with group 12 IV isolates, which developed significant splenomegaly and but had significantly fewer 13 splenic bacteria compared to group I, V and VI mice (p<0.05). 14 Evaluation of histopathology at 28 days p.i. revealed more lesions in SCID mice 15 than in C.B-17 mice (Table S3) Variations in pathology and inflammation associated with these isolate groups infections 2 suggest a difference in the immune response. To expand on this observation, the serum 3 levels of 16 cytokines and chemokines were measured. In C.B-17 mice, serum cytokine 4 levels differed between mice infected with group I isolates and those given isolates from 5 other groups. Group I isolates induced persistently high cytokine secretion throughout the 6 28 day experiment; group IV and V isolates caused moderate cytokine secretion at the 7 peak of clinical disease (7 to 14 days p.i.) (FIG. 3) . After 14 days p.i., group I isolates 8 induced higher secretion of IL-3, IL-4, IL-6, IL-10, IL-12p40, IL-12p70, IFN-γ, TNF-α, 9
MIP-1α, and RANTES when compared with other groups. The KC and G-CSF levels of 10 mice infected with group I isolates were higher than in mice infected with other groups 11 prior to 14 days p.i. Serum levels of IL-1α, IL-1β, IL-2, IL-5, and eotaxin secretion were 12 not increased during the infection period (data not shown). 13
Lethal potential of all genomic groups in SCID mice. The lethal potential of 14 representative isolates from each phylogenetic group was investigated in SCID mice, and 15 it was determined that all of the isolates evaluated could eventually lead to clinical illness 16 and death in the immunodeficient model (FIG. S1B) . Isolates that caused a long period 17 of cachexia led to severe body weight loss in infected mice (FIG. S2) . Group I isolate 18 (NM) induced the earliest and longest period of cachexia and correspondingly the most 19 severe body weight loss. Mice infected with isolates from groups V (G) and VI (Dugway) 20 had similar survival times, but those given group V isolates had longer periods of 21 cachexia and more severe body weight loss than group VI-infected mice. Infection with 22 group IV isolates (Priscilla and P) resulted in the shortest period of cachexia, and body 23 on October 24, 2017 by guest http://iai.asm.org/ Downloaded from weight loss was not observed until the terminal stage of infection. Survival time was 1 shortest in mice challenged with group I isolates (32.0 ± 0.8 days), followed by those 2 infected with groups V (36.0 ± 0.0 days) and VI (35.5 ± 1.0 days), and IV (47.5 ± 0.6 3 days for P and 77.3 ± 2.8 days for Priscilla). Probable cause of death was multiple organ 4 failure due to massive systemic infection. 5
The pathologic changes in SCID mice at mortality were more advanced than those 6 observed at 28 days p.i. (data not shown). The severity of inflammatory changes in the 7 liver and spleen were similar in all groups of infected mice, but animals given group I 8 isolates exhibited a greater degree of inflammation in the heart and lungs than those given 9 group IV, V, and VI isolates. The extent of splenomegaly changed with survival time; 10 however, the number of bacteria in the spleen was similar in all groups, suggesting that 11 the detected amount of bacteria (10 10 genome copy/spleen) is the saturation point in 12 SCID mice. C. burnetii antigen was diffusely distributed in all tissue sections. 13
Genomic group specific outcome of acute Q fever pneumonia in the guinea 14 pig aerosol model. Aerosol-challenge in the guinea pig provides a physiologically 15 relevant model that simulates both the natural route of infection and common clinical 16 presentations associated with human acute Q fever infection, making this a choice model 17 for evaluating the comparative virulence of different C. burnetii isolates and was thus 18 used in the logical progression of experiments after differing virulence were observed in 19 mouse models of infection. Guinea pigs challenged with group I and V isolates developed 20 a significant fever in response to infection (p<0.01), whereas those given isolates from 21 groups IV and VI were afebrile even at the highest challenge dose (FIG. 4) . 22
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Fever response, weight loss, and other clinical signs displayed a dose-dependent 1 relationship in guinea pigs infected with group I C. burnetii isolates African and Ohio as 2 has been described for the reference isolate in this group, NM (43). All animals receiving 3 high-dose African or Ohio organisms died within 7-9 days post infection, as did 2/3 4 receiving NM; lower infectious doses were not lethal. Gross lung consolidation and 5 overall lack of normal body fat were noted on necropsy at 7-9 days p.i. in guinea pigs 6 infected with the highest dose of organisms. Histologically, these animals had severe 7 panleukocytic bronchointerstitial pneumonia with bronchial and alveolar exudates. Lung 8 tissues from the surviving NM-infected guinea pig and those given the mid-dose group I 9 organisms were evaluated at 28 days p.i. for comparison to animals infected with other 10 isolates evaluated at this time-point and exhibited moderate multifocal lymphohistiocytic 11 pneumonia with granuloma formation. 12 No significant fever or other overt clinical signs were noted in guinea pigs 13 infected with group IV isolates. Mild lymphohistiocytic pneumonia was seen 14 histologically at 28 days p.i. in animals delivered the highest dose of organism. 15
Group V isolate infected guinea pigs all developed fever when delivered the 16 highest challenge dose, and dose-dependent temperature increase and other clinical signs 17
were again noted, with no fever development in those animals receiving the lowest dose 18 of organism. Though auscultation confirmed respiratory compromise, none of the 19 infections were lethal. At 28 days p.i., the lungs had a mild to moderate 20 lymphohistiocytic interstitial pneumonia and a few small granulomas. 21
No major clinical or pathologic changes were noted in guinea pigs infected with 22 the group VI isolate or in negative control animals. Table S4 compares Genomic group specific severity of hepatitis and splenomegaly in guinea pigs. 9
The doughnut granulomas common in human acute Q fever hepatitis (31) have not been 10 previously described in animals experimentally infected with C. burnetii and were 11 similarly not seen in the guinea pigs in this study. Mild hepatitis and severe hepatic 12 lipidosis were noted at death 7 days p.i. in guinea pigs challenged with high-dose group I 13 isolates, as has been previously reported for NM aerosol-infected guinea pigs (43). Tissue 14 sections from the remaining NM-infected guinea pig and those infected with the mid-15 dose group I organisms were evaluated for comparison with animals infected with other 16 isolates at 28 days p.i. and revealed vacuolization and degeneration of centrilobular 17 hepatocytes, lymphocyte infiltration in periportal regions, and multiple small granulomas. 18
Group IV infected guinea pigs also had periportal lymphocytic infiltration as well 19 as multiple granulomas of varying sizes. The granulomas in Priscilla-and P-infected 20 guinea pigs were more defined, with more histiocytic involvement than was seen in 21 guinea pigs infected with group I isolates. Subjectively, of all animals necropsied from 22
on October 24, 2017 by guest http://iai.asm.org/ Downloaded from each isolate group, hepatic granulomas from those infected with P were the greatest in 1 size and number. 2
The livers of group V isolate G-and S-infected guinea pigs contained few small 3 granulomas and mild to moderate infiltration of lymphocytes along portal tracts. The 4 hepatic changes observed in guinea pigs infected with group V isolates suggested that 5
isolates from this group are less hepatovirulent than group IV isolates but more than 6 group I isolates. 7
No hepatic granulomas or other significant pathologic changes were noted in 8 guinea pigs infected with the group VI isolate Dugway. Liver weights did not vary 9 significantly within or between genomic groups. 10
There were no significant differences in spleen weight at 28 days p.i. within or 11 between genomic or dose groups. Animals infected with all isolates examined at 14 days 12 p.i. (NM, P, G, and Dugway) had significantly larger spleens than PBS control animals, 13 and spleens from NM-and G-infected guinea pigs were significantly larger (p<0.01 and 14 p<0.05, respectively) than those of P-and Dugway-infected animals (FIG. S3) . 15
Pathologic findings included multiple small granulomas in the spleens of group I-infected 16 guinea pigs; fewer small granulomas were occasionally noted in animals infected with 17 group IV and V isolates. 18
Heterologous protection of cross vaccination and challenge in guinea pigs. 19
The infection studies described in this paper illustrate that there is pathotype diversity 20 between C. burnetii isolates from different genogroups and are consistent with 21 phylogenetic studies cataloging distinct gene content (4) . We therefore strove to 22 determine whether this diversity was great enough to affect the ability of vaccines to 23 protect against infection. Guinea pigs were given group I (NM) or group IV (S) vaccines 1 and cross-challenged to evaluate potential heterologous protection against high-dose 2 infection. Non-vaccinated guinea pigs developed a noticeable fever response by day 5 3 p.i., and infection was lethal in 3/3 NM and 1/3 S challenged animals. Guinea pigs 4 vaccinated with either formalin-killed NM or S were completely protected against fever 5 development and death when challenged with either NM or S (FIG. 5) . 6
The potential for genomic group-specific pathogenicity of C. burnetii was 9 evaluated using immunocompetent mice and guinea pigs and immunodeficient mice. The 10 hypotheses that isolates belonging to the same genomic group would cause similar 11 disease and that there would be distinctions in disease manifestations between isolate 12 groups were supported by the findings presented here. 13
A detailed analysis of Priscilla isolate dose-effect in SCID mice revealed 14 differences in virulence of C. burnetii isolates. Disease development after Priscilla 15 infection was progressive but slower compared to the disease caused by NM previously 16 reported in SCID mice (1); the survival time of SCID mice infected with Priscilla was 17 longer with the same LD 50 dose. This result supports the previous study by Moos and 18
Hackstadt that evaluated the lower ability of the Priscilla isolate to cause fever in IP-19 challenged guinea pigs (36). Interestingly, the mice infected with Priscilla did not exhibit 20 cachexia until the terminal stages of infection when they had extremely severe 21 hepatosplenomegaly. Although the disease caused by Priscilla was milder than that 22 associated with NM, all mice that developed clinical illness died. This result confirms a 23 high infectivity and lethal potential of C. burnetii that is not restricted to acute isolates 1 and suggests that the SCID mouse model can be useful for evaluation of C. burnetii 2 virulence. 3
The virulence of C. burnetii isolates tested in SCID mice was determined to be 4 genomic group-specific. Acute Q fever associated group I isolates caused the most 5 rapidly progressing disease and the most severe pathologic changes. Groups IV and V, 6 isolates associated with chronic Q fever, caused a slower progression of disease. Overall, 7 pathologic changes in mice infected with group IV and V isolates were milder than those 8 of group I infected mice. The number of bacteria in the spleen at 28 days p.i. was greater 9 in mice with severe disease from infection with group I isolates; however, bacterial load 10 at the time of death was similar in all infected mice. This suggests that the rate of 11 proliferation of C. burnetii in vivo may be virulence-related. An in vitro comparison of 12 infection in L929 cells using NM, Priscilla, and S isolates showed that all isolates can 13 persistently infect, but Priscilla requires a greater period of time to establish an infection 14 (42), and it has been shown that inclusion forming units produced by NM and Priscilla 15 isolates were similar in Vero cells (36). However, because of developmental differences 16 in clinical signs and pathologic changes, replication rate does not seem to be the only 17 virulence factor involved since clinical signs then would be similar with differences in 18 disease progression only. At both time points, 28 days p.i. and at time of death due to 19 infection, heart and lung lesions caused by group IV, V, and VI isolates were milder than 20 those produced by infection with group I isolates. This observation seems to conflict with 21 the hypothesis that chronic isolates cause chronic Q fever, including heart disease. 22
However, our observation is consistent with the report that isolates from heart lesions of 23 chronic Q fever patients have similar genetic characteristics to acute isolates (46). The 1 hypothesis that acute isolates do not cause endocarditis has been supported by two other 2 research groups (17, 24) . The correlation between virulence and phylogeny has been 3 controversial because of a lack of comprehensive studies. One study detected acute 4 isolate specific genes in isolates from chronic Q fever patients and concluded that isolates 5
were not disease-specific (46). The isolates used in the study were isolated by cell 6 culture, and though the cell culture system is highly effective for isolation, acute isolates 7 are known to infect cultured cells more efficiently than chronic isolates, so there remains 8 a potential that the study collected only cell culture-adapted isolates. Several in vivo 9 studies have reported isolate-specific virulence using guinea pig and mouse models (17, 10 24, 36) ; however, the number of isolates used in these studies was limited, making it 11 difficult to conclude genomic group-specific virulence. The present study using eight 12
isolates from four phylogenetic groups strongly supports the variation in virulence among 13 C. burnetii isolate groups. 14 In the absence of functional T and B cells, cytokine profiles showed no group-15 specific differences. In immunocompetent mice group I isolates caused a stronger 16 immune response with high levels of multiple cytokines over a longer time period than 17 other groups. Interestingly, Dugway (group VI) induced the least change in C.B-17 mice. 18
The inflammatory cytokine changes in immunocompetent mice in this study were similar 19 to those of humans with acute Q fever (10): TNF-α and IL-6 were upregulated, but IL-1β 20 was not. IFN-γ increased in C.B-17 mice infected with group I isolates, and is associated 21 with the control of bacterial growth, stimulates phagosome-lysosome fusion, and may 22 enable monocytes/macrophages to kill C. burnetii (13, 14) . A difference in vacuole 23 formation between isolates has also been shown, with NM and S developing within single 1 large vacuoles while Priscilla occupied several smaller vacuoles per cell (18). This in 2 vitro study suggested a difference in isolate ecology within host cells, which may 3 correlate with their virulence in vivo. 4
The ability to cause fever and respiratory illness was isolate and dose dependent 5 in the guinea pig aerosol-challenge model, with isolates from groups I and V causing 6 disease consistent with human acute Q fever. Isolates within the same genomic group 7 produced similar clinical illness, strongly supporting the mouse experiments 8 demonstrating that genomic differences in the bacterial isolates do play a role in 9 virulence. It was shown here that isolates associated with chronic disease, G and S, have 10 the ability to cause acute disease in the guinea pig model. Our study confirmed and Luga vaccines and that whole-cell vaccines were more effective than soluble vaccines 17 (28) . In the guinea pig challenge study presented here, killed whole cell vaccines made 18 from isolates differing in LPS banding pattern (16), plasmid type (44), and genomic 19 group (20), specifically isolates from groups I and V, conferred heterologous protection 20 against virulent high dose challenge in accordance with previous studies (28) . This 21 suggests that although the manifestation of disease and genomic content differ among 22 various isolate groups, the antigenic properties of whole cell vaccines are shared enough 23 that cross protection is possible. Such information is valuable for new vaccine design and 1 could be of utmost importance in offering reliable protection in the event of an outbreak. 2
The differences in perceived infectious dose noted when OD, particle count, and 3 genome copy enumeration were compared underline the importance of using multiple 4 quantitation methods to compare studies with earlier observation. Some of the differences 5 in disease manifestation seen in guinea pigs in this study could be due to slight 6 differences in infectious dose delivered. For instance, Priscilla and P both induced hepatic 7 changes, though guinea pigs infected with P appeared to induce more severe lesions than 8
Priscilla, which had a lower infectious dose by OD and qPCR. The difference in 9 infectious dose as determined by genome copy number could account for this variation. 10 However, G and S both caused fever, and although guinea pigs infected with G did not 11 attain the same degree of febrile response as S infected animals, quantitation by particle 12 count and real-time PCR showed infectious doses of S to be over a log lower than G. It 13 could be argued that Priscilla infected guinea pigs did not develop fever because fewer 14 bacteria were present in the aerosol challenge; however, the group IV isolates did not 15 induce fever at any of the challenge doses while group I isolates induced fever even at the 16 lowest dose. We believe that despite the variation in infectious dose depending on 17 enumeration technique, the significant differences noted among genotypic groups are 18
valid. 19
Phase variation is the only well characterized phenotypic difference that relates to 20 virulence in C. burnetii (50). Although LPS may be a major virulence determinant, and 21 isolate LPS banding patterns have been correlated with acute or chronic disease (16), 22 other components alone or in association with LPS may be responsible for differences in 23 mortality in SCID mice and fever development in aerosol-challenged guinea pigs. It has 1 been hypothesized that differences in the lipid A component are responsible for the 2 variations in virulence, but lipid structural information indicates they are similar. The 3 combination of a variety of factors expressed by phase I bacteria likely govern the ability 4 of C. burnetii to infect cells and maintain continuous growth within the phagolysosome. 5
Indeed, the combination of pathotype variation of disease in infected guinea pigs and 6 cross-protection of different isolates suggest conserved predominant antigenic 7 components and with virulence determinant specificity. 8
A recent report compared all open reading frames (ORF) of NM phase I to 9
African, Ohio, P, G, S, and Dugway, among others (4), and a majority of the ORFs 10 deleted from Nine Mile in the other isolates were either hypothetical or nonfunctional; 11 however, a few were associated with assorted cellular functions. Beare et al. compared 12 the complete genome sequences of NM, K, G, and Dugway and found distinct collections 13 of psuedogenes and unique gene content that may contribute to pathotype-specific 14 virulence including type II and type IV secreted effector molecules (5) . Integrating our in 15 vivo data with these molecular details, as well as with other in vitro studies, may reveal 16 the critical virulence determinants of C. burnetii and ultimately identify targets for 17 vaccine and therapeutic intervention. 18
Isolates of phase I C. burnetii have the potential to cause a range of clinical signs, 19 including fever, pneumonia, hepatitis, and splenomegaly. Isolates from one human 20 chronic disease group induced mild to moderate acute disease in the physiologically 21 relevant guinea pig aerosol-challenge model while a separate isolate group representing 22 several chronic disease isolates caused no acute disease. All isolates examined were 23 capable of producing disease in the immunocompromised SCID mouse model, and 1 genogroup-consistent trends were noted in cytokine production in response to infection in 2 the immunocompetent mouse model. In these studies, isolates within the same genomic 3 group caused similar pathologic responses, with a distinction in strain virulence between 4 established genogroups, sustaining the theory that genetic differences in the bacterial 5 isolates affect their virulence. We are grateful to Laura R. Hendrix for critical review of this manuscript. 12 
